Literature DB >> 28138950

What is the optimal surgical strategy for complex perianal fistulous disease in pediatric Crohn's disease? A systematic review.

Navot Kantor1,2, Carolyn Wayne1, Ahmed Nasr3,4.   

Abstract

PURPOSE: Perianal fistulous disease is present in 10-15% of children with Crohn's disease (CD) and is frequently complex and refractory to treatment, with one-third of patients having recurrent lesions. We conducted a systematic review of the literature to examine the best surgical strategy or strategies for pediatric complex perianal fistulous disease (CPFD) in CD.
METHODS: We searched CENTRAL, MEDLINE, EMBASE, and CINAHL for studies discussing at least one surgical strategy for the treatment of pediatric CPFD in CD. Reference lists of included studies were hand-searched. Two researchers screened all studies for inclusion, quality assessed each relevant study, and extracted data.
RESULTS: One non-randomized prospective and two retrospective studies met our inclusion criteria. Combined use of setons and infliximab therapy shows promise as a first-line treatment. A specific form of fistulectomy, "cone-like resection," also shows promise when combined with biologics. Endoscopic ultrasound to guide medical and surgical management is feasible in the pediatric population, though it is unclear if it improves outcomes.
CONCLUSION: There is a paucity of evidence regarding the treatment of CPFD in the pediatric population, and further research is required before recommendations can be made as to what, if any, surgical management is optimal.

Entities:  

Keywords:  Crohn’s disease; Pediatric surgery; Perianal fistula; Systematic review

Mesh:

Year:  2017        PMID: 28138950     DOI: 10.1007/s00383-017-4067-6

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  40 in total

1.  Methodological index for non-randomized studies (minors): development and validation of a new instrument.

Authors:  Karem Slim; Emile Nini; Damien Forestier; Fabrice Kwiatkowski; Yves Panis; Jacques Chipponi
Journal:  ANZ J Surg       Date:  2003-09       Impact factor: 1.872

Review 2.  AGA technical review on perianal Crohn's disease.

Authors:  William J Sandborn; Victor W Fazio; Brian G Feagan; Stephen B Hanauer
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

3.  The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

Review 4.  The case of the misleading funnel plot.

Authors:  Joseph Lau; John P A Ioannidis; Norma Terrin; Christopher H Schmid; Ingram Olkin
Journal:  BMJ       Date:  2006-09-16

5.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

6.  Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study.

Authors:  Paulo Gustavo Kotze; Idblan Carvalho de Albuquerque; André da Luz Moreira; Wanessa Bertrami Tonini; Marcia Olandoski; Claudio Saddy Rodrigues Coy
Journal:  Arq Gastroenterol       Date:  2014 Oct-Dec

7.  Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease.

Authors:  Jean-Charles Grimaud; Nicolas Munoz-Bongrand; Laurent Siproudhis; Laurent Abramowitz; Agnès Sénéjoux; Véronique Vitton; Luc Gambiez; Bernard Flourié; Xavier Hébuterne; Edouard Louis; Benoit Coffin; Vincent De Parades; Guillaume Savoye; Jean-Claude Soulé; Yoram Bouhnik; Jean-Frédéric Colombel; Jean-François Contou; Yves François; Jean-Yves Mary; Marc Lémann
Journal:  Gastroenterology       Date:  2010-02-20       Impact factor: 22.682

8.  Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.

Authors:  Dawnelle R Topstad; Remo Panaccione; John A Heine; Douglas R E Johnson; Anthony R MacLean; W Donald Buie
Journal:  Dis Colon Rectum       Date:  2003-05       Impact factor: 4.585

9.  Efficacy and tolerance of infliximab in children and adolescents with Crohn's disease.

Authors:  Thierry Lamireau; Jean-Pierre Cézard; Alain Dabadie; Olivier Goulet; Alain Lachaux; Dominique Turck; Chantal Maurage; Alain Morali; Etienne Sokal; Dominique Belli; Joaquim Stoller; Samy Cadranel; Jean-Louis Ginies; Sheila Viola; Frédéric Huet; Jane Languepin; Catherine Lenaerts; Françoise Bury; Jacques Sarles
Journal:  Inflamm Bowel Dis       Date:  2004-11       Impact factor: 5.325

10.  Surgery for symptomatic hemorrhoids and anal fissures in Crohn's disease.

Authors:  A F Wolkomir; M A Luchtefeld
Journal:  Dis Colon Rectum       Date:  1993-06       Impact factor: 4.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.